Foster & Motley Inc. Takes $11.03 Million Position in HCA Healthcare, Inc. $HCA

Key Points

• Foster & Motley Inc. purchased 28,296 HCA Healthcare shares worth approximately $11.03 million in the second quarter. Institutional investors collectively own 62.73% of the company.
• HCA Healthcare exceeded quarterly expectations, reporting $7.59 in EPS and $20.23 billion in revenue, with revenue rising 8.7% year over year.
• The company declared a quarterly dividend of $0.78 per share, or $3.12 annualized, while analysts maintain a “Moderate Buy” consensus and an average price target of $465.59.

Foster & Motley Inc. purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 28,296 shares of the company's stock, valued at approximately $11,032,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Brighton Jones LLC purchased a new stake in shares of HCA Healthcare in the fourth quarter worth $1,021,000. NewEdge Advisors LLC boosted its holdings in HCA Healthcare by 11.9% in the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company's stock worth $1,334,000 after buying an additional 409 shares during the period. Sivia Capital Partners LLC raised its holdings in HCA Healthcare by 5.5% during the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company's stock valued at $241,000 after acquiring an additional 33 shares during the period. Jump Financial LLC bought a new position in shares of HCA Healthcare in the second quarter worth about $2,073,000. Finally, Sei Investments Co. raised its stake in HCA Healthcare by 56.3% during the 2nd quarter. Sei Investments Co. now owns 136,589 shares of the company's stock valued at $52,328,000 after purchasing an additional 49,214 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Stock Performance

NYSE HCA opened at $412.27 on Wednesday. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52. The company has a market cap of $89.26 billion, a P/E ratio of 13.80, a P/E/G ratio of 1.40 and a beta of 1.10. The business's 50 day moving average price is $395.07 and its 200-day moving average price is $445.35.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating the consensus estimate of $7.56 by $0.03. The company had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The firm's revenue was up 8.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $6.84 EPS. As a group, equities analysts predict that HCA Healthcare, Inc. will post 29.47 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is 10.45%.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the stock. Cantor Fitzgerald reduced their price objective on shares of HCA Healthcare from $588.00 to $525.00 and set an "overweight" rating on the stock in a research report on Tuesday, July 7th. KeyCorp cut their target price on shares of HCA Healthcare from $475.00 to $435.00 and set an "overweight" rating for the company in a research note on Monday, July 27th. Robert W. Baird dropped their price objective on shares of HCA Healthcare from $396.00 to $393.00 and set a "neutral" rating for the company in a report on Monday, July 27th. Stephens decreased their target price on HCA Healthcare from $560.00 to $530.00 and set an "overweight" rating on the stock in a research report on Monday, April 27th. Finally, Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $435.00 price objective on shares of HCA Healthcare in a research note on Monday, July 27th. Fourteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $465.59.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source